← Open Payments lookup

ELIZABETH BRUSHABER: Open Payments

NPI 1477144939 · BILOXI, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,374 in 76 payments from 18 companies in 2025. Trend: 2023 $1,409 · 2024 $1,223 · 2025 $1,374

Food & beverage: $1,374
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.7$172
Novo Nordisk Inc11$155
Novartis Pharmaceuticals Corporation7$152
Amgen Inc.9$137
AstraZeneca Pharmaceuticals LP7$111
Sumitomo Pharma America, Inc.5$96
GlaxoSmithKline, LLC.5$91
Boehringer Ingelheim Pharmaceuticals, Inc.5$79
Astellas Pharma US Inc4$69
Lilly USA, LLC4$66

Products named: REXULTI, LEQVIO, GEMTESA, OTEZLA, Ozempic, JARDIANCE, Veozah, MOUNJARO.

Industry payments across MS — which companies pay providers there.